Verbatim response from Claude
How to Evaluate FDA Compliance for Compounded Semaglutide Pharmacies
This is an important question since the compounded semaglutide market has significant quality and safety variation.
Key Things to Check
Pharmacy Licensing
- Look for 503A (patient-specific) or 503B (outsourcing facility) FDA registration
- 503B facilities have stricter oversight and are listed on the FDA's website - you can verify directly at fda.gov
- Check your state board of pharmacy to confirm active licensure
Red Flags to Watch For
- Selling without a valid prescription
- Unusually low prices
- No licensed prescriber involvement
- Claims that their version is "equivalent" to Ozempic/Wegovy
- Shipping internationally from unregulated facilities
Relatively Reputable Options to Consider
- Hims & Hers - uses licensed compounding pharmacies with prescriber oversight
- Ro - partners with verified compounding pharmacies
- Henry Meds - transparent about pharmacy sourcing
- LifeMD - works with licensed pharmacy partners
Important Current Context
The FDA has declared semaglutide shortage resolved, which means compounding may soon become legally restricted. Check the FDA's shortage database for the latest status.
Best Practice
Ask any pharmacy to name their compounding facility and verify it on the FDA's 503B database yourself.
Want help evaluating a specific pharmacy?